Eva Cwynar
Endocrinology, Diabetes & Metabolism · Beverly Hills, CANPI 1558487835
Payments from drug & device makers
Across 313 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Lilly USA, LLC$919
- Currax Pharmaceuticals LLC$376
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$373
- Corium, LLC$323
- Pfizer$173
- plus $1K from 19 others
What the payments were for
- Food & beverage$5,02199%
- Education$711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 134 | $1,610 |
| Lilly USA, LLC | 40 | $919 |
| Currax Pharmaceuticals LLC | 24 | $376 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $373 |
| Corium, LLC | 23 | $323 |
| Pfizer | 5 | $173 |
| Mannkind Corporation | 9 | $161 |
| Ascendis Pharma Endocrinology Inc | 5 | $129 |
| Acella Pharmaceuticals, LLC | 7 | $107 |
| Idorsia Pharmaceuticals US Inc | 6 | $106 |
| Antares Pharma, Inc. | 5 | $97 |
| Exact Sciences | 4 | $97 |
| Amgen | 4 | $82 |
| IBSA Pharma Inc. | 4 | $76 |
| Tolmar, Inc. | 3 | $68 |
| Abbott | 3 | $68 |
| Acerus Pharmaceuticals Corporation | 3 | $62 |
| AbbVie | 2 | $56 |
| Vivus LLC | 2 | $49 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| AstraZeneca | 2 | $31 |
| Avion Pharmaceuticals | 2 | $30 |
| Ironwood Pharmaceuticals, Inc | 1 | $27 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Cequr Corporation | 1 | $15 |
How this compares
$5,091 in reported general payments places this provider in the 65th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 30 | $28,872 |
| TirosintLevothyroxine Sodium | 36 | $4,939 |
| SynthroidLevothyroxine Sodium | 63 | $3,293 |
| Armour ThyroidThyroid,pork | 17 | $668 |
| Liothyronine Sodium | 17 | $535 |
| Bupropion XlBupropion Hcl | 15 | $438 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $265 |
| Trazodone Hcl | 22 | $188 |
| ValacyclovirValacyclovir Hcl | 12 | $171 |
| Spironolactone | 14 | $152 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $148 |
| Topiramate | 17 | $127 |
| Rosuvastatin Calcium | 12 | $115 |
| Buspirone Hcl | 13 | $111 |
| Alprazolam | 19 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $919 | $28,87230 claims |
| IBSA Pharma Inc.Tirosint | $76 | $4,93936 claims |
| AbbVieSynthroid, Armour Thyroid | $56 | $3,96180 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 952 endocrinology, diabetes & metabolism providers in California.
Other endocrinology, diabetes & metabolism in Beverly Hills
- Pejman CohanBeverly Hills$2.2M
- Anne PetersBeverly Hills$560K
- Jerrold OlefskySan Diego$26.5M
- Mark ChristiansenWalnut Creek$22.9M
- Timothy BaileyEscondido$22.3M
- Stanley HsiaLos Angeles$19.8M
- Juan FriasSan Diego$14.1M
- Paul NorwoodFresno$6.2M
- Athena Philis-Tsimikasla Jolla$6M
- David AhnNewport Beach$5.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.